FGF23 and chronic kidney disease: The gathered data suggested that elevated levels of cardiac FGF23 might have induced LVH through paracrine mechanisms, stimulating FGFR4 and activating the calcineurin-NFAT signaling pathway, particularly in the context of Klotho deficiency, i.e., CKD.